Security National Financial director adds shares via option exercise
Rhea-AI Filing Summary
Security National Financial Corp. (SNFCA) – Form 4 insider filing
Director H. Craig Moody reported one transaction dated 07/01/2025:
- 628 shares of Class A Common Stock acquired (Transaction Code M) at a stated price of $13.08 per share, raising his direct ownership to 41,024 shares.
- The acquisition appears to stem from the conversion/vesting of previously granted Restricted Stock Units, as reflected by a matching 628-unit entry in Table II.
Table II also lists the director’s outstanding 57,163 option-equivalent derivative securities and RSUs with exercise prices ranging from $2.99 – $7.59 (options) and $13.08 (RSUs), expiring between 2026-2033. No dispositions were reported.
Positive
- Director increased his direct stake by 628 shares with no accompanying sales, signaling confidence.
Negative
- None.
Insights
TL;DR – Routine insider option exercise; modest bullish signal, limited market impact.
The Form 4 shows a director converting 628 RSUs/options at $13.08, increasing his direct stake to 41,024 shares. No shares were sold, suggesting confidence rather than liquidity-driven selling. However, the dollar value (~$8k) and share count are immaterial relative to typical trading volumes, so immediate price impact should be minimal. The filing does confirm substantial unexercised options (57,163), which could become dilutive over time but are already disclosed in prior equity plans. Overall, the event is neutral-to-slightly positive for sentiment but not financially material.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 628 | $13.08 | $8K |
| Exercise | Class A Common Stock | 628 | $13.08 | $8K |
| Grant/Award | Restricted Stock Unit | 1,882 | $13.08 | $25K |
| Grant/Award | Director Stock Option (right to buy) | 8,400 | $7.59 | $64K |
| Grant/Award | Director Stock Option (right to buy) | 7,718 | $5.85 | $45K |
| Grant/Award | Director Stock Option (right to buy) | 6,946 | $7.39 | $51K |
| Grant/Award | Director Stock Option (right to buy) | 7,476 | $2.99 | $22K |
| Grant/Award | Director Stock Option (right to buy) | 7,850 | $4.12 | $32K |
| Grant/Award | Director Stock Option (right to buy) | 8,244 | $3.96 | $33K |
| Grant/Award | Director Stock Option (right to buy) | 1,442 | $3.44 | $5K |
| Grant/Award | Director Stock Option (right to buy) | 1,514 | $4.76 | $7K |
| Grant/Award | Director Stock Option (right to buy) | 7,573 | $4.55 | $34K |
Footnotes (1)
- This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024. This option was granted on December 7, 2016 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.36 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024. This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024. This option was granted on November 30, 2018 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024. This option was granted on December 6, 2019 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.46 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024. This option was granted on March 27, 2020 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $3.76 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020, a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024. This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023 and July 12, 2024. This option was granted on December 2, 2022 as an option for 7,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $6.48, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 14, 2023 and July 12, 2024. This option was granted on December 1, 2023 as an option for 8,000 shares of Class A Common Stock under the 2022 Equity Incentive Plan at an exercise price of $7.99 per share, but adjusted pursuant to the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 12, 2024. These restricted stock units were granted on December 6, 2024 for 2,509 shares of Class A Common Stock under the 2022 Equity Incentive Plan at a price of $13.08 per share. The units granted vest quarterly, and will be fully vested on December 31, 2025.